Janus Henderson Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $116K | Hold |
|
|||||
|
2024
Q3 | $198K | Hold |
|
|||||
|
2024
Q2 | $98.1K | Sell |
|
|||||
|
2024
Q1 | $189K | Buy |
|
|||||
|
2023
Q4 | $339K | Sell |
|
|||||
|
2023
Q3 | $443K | Buy |
|
|||||
|
2023
Q2 | $976K | Sell |
|
|||||
|
2023
Q1 | $1.24M | Buy |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $1.28M | Buy |
|
|||||
|
2022
Q2 | $190K | Sell |
|
|||||
|
2022
Q1 | $269K | Buy |
|
|||||
|
2021
Q4 | $225K | Buy |
|